These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38222188)

  • 1. A Case of Anti-vascular Endothelial Growth Factor Therapy-Related Nephrotic Syndrome With Marked Intraglomerular Macrophage Infiltration.
    Obara S; Inoue T; Watanabe Y; Hamaguchi T; Ikezawa T; Amano H; Ishizawa K; Okada H
    Cureus; 2023 Dec; 15(12):e50496. PubMed ID: 38222188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab-associated glomerular microangiopathy that occurred after postoperative chemotherapy for ovarian cancer.
    Morimoto M; Arai T; Matsuura M; Ono Y
    CEN Case Rep; 2021 Feb; 10(1):6-11. PubMed ID: 32642991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience.
    Ozawa M; Ohtani H; Komatsuda A; Wakui H; Takahashi N
    Clin Exp Nephrol; 2021 Nov; 25(11):1193-1202. PubMed ID: 34115234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature.
    Yahata M; Nakaya I; Sakuma T; Sato H; Aoki S; Soma J
    BMC Res Notes; 2013 Nov; 6():450. PubMed ID: 24207130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema.
    Kikuchi Y; Odashima Y; Yoshikawa K; Oda T; Tanaka F; Oikawa H; Ishigaki Y; Asahi K
    BMC Nephrol; 2022 Oct; 23(1):348. PubMed ID: 36309669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of thrombotic microangiopathy with glomerular subendothelial IgA deposition due to bevacizumab].
    Tomita M; Ochiai M; Shu S; Yamauchi Y; Shihara H; Ogata A; Fujisawa N; Yanai Y; Kamata T; Iehara N
    Nihon Jinzo Gakkai Shi; 2014; 56(5):612-7. PubMed ID: 25130034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function.
    Haraguchi K; Hara S; Ubara Y; Tanaka S; Nukui I; Shimura H; Ohashi K; Kobayashi T
    Diabetes Res Clin Pract; 2009 Mar; 83(3):295-9. PubMed ID: 19162360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cases of Advanced Colorectal Cancer with Nephrotic Syndrome after FOLFIRI plus Ramucirumab Administration].
    Nakura M; Nojima K; Yamazaki H; Takenaka S; Watanabe T; Takeshita M; Sasaki S; Fujimura T
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1745-1747. PubMed ID: 36732986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab-associated glomerular microangiopathy.
    Person F; Rinschen MM; Brix SR; Wulf S; Noriega MLM; Fehrle W; Schmitz J; Schwarz A; Ivanyi P; Steinmetz OM; Reinhard L; Hoxha E; Zipfel PF; Bräsen JH; Wiech T
    Mod Pathol; 2019 May; 32(5):684-700. PubMed ID: 30552416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular Microangiopathy with Cellular Crescent-like Formation and Endotheliopathy Due to Ramucirumab Treatment for Metastatic Sigmoid Colon Cancer.
    Yoshimura Y; Sawa N; Matsuoka S; Ikuma D; Oba Y; Sekine A; Hasegawa E; Mizuno H; Yamanouchi M; Suwabe T; Hoshino J; Kono K; Kinowaki K; Ohashi K; Toda S; Matoba S; Wakui H; Ubara Y
    Intern Med; 2022 Dec; 61(23):3547-3552. PubMed ID: 35569979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive bevacizumab-associated renal thrombotic microangiopathy.
    Uy AL; Simper NB; Champeaux AL; Perkins RM
    NDT Plus; 2009 Feb; 2(1):36-9. PubMed ID: 25949282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy.
    Nishi K; Sato M; Ogura M; Okutsu M; Ishikura K; Kamei K
    BMC Nephrol; 2020 Aug; 21(1):323. PubMed ID: 32746791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
    Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
    BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal-Limited Thrombotic Microangiopathy due to Bevacizumab Therapy for Metastatic Colorectal Cancer: A Case Report.
    Toriu N; Sekine A; Mizuno H; Hasegawa E; Yamanouchi M; Hiramatsu R; Hayami N; Hoshino J; Kawada M; Suwabe T; Sumida K; Sawa N; Takaichi K; Ohashi K; Fujii T; Matoba S; Ubara Y
    Case Rep Oncol; 2019; 12(2):391-400. PubMed ID: 31244641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Nephrotic Syndrome Induced by FOLFIRI plus Ramucirumab for Metastatic Descending Colon Cancer].
    Shingai T; Fukuzaki T; Okimura S; Ito Y; Taniguchi Y; Fukata T; Nishida H; Takayama O; Yoshioka S; Hojo S; Ohigashi H
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2155-2157. PubMed ID: 32156863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
    Yılmaz S; Özçakar ZB; Taktak A; Kiremitçi S; Ensari A; Dinçaslan H; Yalçınkaya F
    Pediatr Nephrol; 2016 Jun; 31(6):1029-32. PubMed ID: 26928310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic Correlation with Renal Dysfunction after Intravitreal Injections of Vascular Endothelial Growth Factor Antagonists.
    Zhang PL; Raza S; Li W; Kanaan HD
    Ann Clin Lab Sci; 2021 Nov; 51(6):875-882. PubMed ID: 34921042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis.
    Kang BW; Kim TW; Lee JL; Ryu MH; Chang HM; Yu CS; Kim JC; Kim JH; Kang YK; Lee JS
    Med Oncol; 2009; 26(1):32-7. PubMed ID: 18498064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable clinical course of patients experiencing bevacizumab-induced proteinuria.
    Saloustros E; Androulakis N; Vamvakas L; Mavroudis D; Georgoulias V
    Case Rep Oncol; 2010 Oct; 3(3):368-71. PubMed ID: 21537380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.